UK’s Department for Business, Innovation, Science and Trade: Helping MedTech companies expand into Hong Kong and Asia-Pacific

As Asia-Pacific continues to attract growing investment in healthcare and life sciences, Hong Kong remains an important destination for MedTech companies looking to establish a regional presence. With its international business environment, strong connectivity and access to the Greater Bay Area (GBA), the city offers a strategic base for companies expanding into Asian markets.

The UK’s Department for Business, Innovation, Science and Trade (BIST), represented in Hong Kong through the British Consulate-General, supports UK businesses by providing export guidance, market access support and strategic advice. Ahead of MedTech World Asia 2026, the Department shares its perspective on the opportunities Hong Kong presents for UK MedTech companies and how businesses can approach expansion across the region.

Supporting UK businesses overseas

The British Consulate-General Hong Kong plays an important role in maintaining and strengthening relations between the United Kingdom, Hong Kong and Macao while supporting the UK’s commercial ties in the region.

Operating within the Consulate, BIST drives good growth, good jobs and opportunity across the UK. The Department supports businesses to invest, innovate, export and grow, powered by science and technology. In Hong Kong, the team draws on this network to help UK companies navigate the local market and build lasting commercial partnerships.

Hong Kong’s role as a regional gateway

Hong Kong has long served as a gateway to Asia, offering businesses access to one of the world’s most dynamic healthcare markets. For UK MedTech and healthcare companies, it provides both commercial opportunities and a strategic base for regional expansion.

Companies establishing a presence in Hong Kong can connect with customers, clinical partners, investors and distribution networks across Asia while operating within a well-established international business environment. Combined with growing government support for healthcare innovation, the city offers an attractive platform for companies looking to expand throughout the Asia-Pacific region.

Helping businesses navigate new markets

Expanding into a new market presents both opportunities and challenges. Companies must understand local market dynamics, identify the right partners and navigate unfamiliar business environments.

BIST works with UK healthcare and MedTech companies to reduce market-entry risks and accelerate growth through practical commercial support. This includes market intelligence, stakeholder introductions, trade missions, sector-focused events and ongoing guidance designed to help businesses identify opportunities and build sustainable operations across Hong Kong, the Asia-Pacific region and beyond.

Connecting with BIST at MedTech World Asia 2026

For UK companies considering expansion into Asia, MedTech World Asia 2026 offers an opportunity to engage directly with the Department’s team in Hong Kong and gain practical insights into doing business across Hong Kong, GBA and the wider Asia-Pacific region.

Whether a company is exploring its first overseas market or looking to strengthen its existing operations in Asia, the event provides a platform for meaningful conversations with industry stakeholders and government representatives who can help businesses better understand the regional ecosystem and available opportunities.

Join the conversation at MedTech World Asia 2026

Taking place from 26–28 August 2026 at the Hong Kong Convention and Exhibition Centre (HKCEC), MedTech World Asia 2026 will bring together founders, investors, healthcare providers, policymakers and industry leaders from across the region. The programme will explore topics including market access, investment, digital health, AI, diagnostics, robotics and strategic partnerships, alongside dedicated networking opportunities designed to foster cross-border collaboration. Be part of the dialogue now.